Abstract
The Gemini analogs are the last significant contribution to the family of vitamin D derivatives in medicine, for the treatment of cancer. The first Gemini analog was characterized by two symmetric side chains at C-20. Following numerous modifications, the most active analog bears a C-23-triple bond, C-26, 27- hexafluoro substituents on one side chain and a terminal trideuteromethylhydroxy group on the other side chain. This progression was possible due to improvements in the synthetic methods for the preparation of these derivatives, which allowed for increasing molecular complexity and complete diastereoselective control at C-20 and the substituted sidechains.
Keywords: Chemical synthesis, Gemini analogs, Steroid, Vitamin D.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Gemini Analogs of Vitamin D
Volume: 14 Issue: 21
Author(s): Gonzalo Pazos, Marcos L. Rivadulla, Xenxo Perez-García, Zoila Gandara and Manuel Perez
Affiliation:
Keywords: Chemical synthesis, Gemini analogs, Steroid, Vitamin D.
Abstract: The Gemini analogs are the last significant contribution to the family of vitamin D derivatives in medicine, for the treatment of cancer. The first Gemini analog was characterized by two symmetric side chains at C-20. Following numerous modifications, the most active analog bears a C-23-triple bond, C-26, 27- hexafluoro substituents on one side chain and a terminal trideuteromethylhydroxy group on the other side chain. This progression was possible due to improvements in the synthetic methods for the preparation of these derivatives, which allowed for increasing molecular complexity and complete diastereoselective control at C-20 and the substituted sidechains.
Export Options
About this article
Cite this article as:
Pazos Gonzalo, Rivadulla L. Marcos, Perez-García Xenxo, Gandara Zoila and Perez Manuel, Gemini Analogs of Vitamin D, Current Topics in Medicinal Chemistry 2014; 14 (21) . https://dx.doi.org/10.2174/1568026615666141208100411
DOI https://dx.doi.org/10.2174/1568026615666141208100411 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recurrence in Bladder Cancer: A Molecular Dead End?
Current Genomics Hypocholesterolemia
Current Vascular Pharmacology Predicting the Intention to Preconception Care on the Basis of Planning Behavior Theory in Women Referred to the Marriage Counseling Centers in Asadabad in 2015
Current Women`s Health Reviews Modification of Polyfluoro-Containing 3-(Ethoxycarbonyl)flavones by Biogenic Amines and Amino Acids
Current Organic Synthesis Part II: Targeted Particles for Imaging of Anticancer Immune Responses
Current Drug Delivery Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Current Drug Targets Mechanisms of the Penetration of Blood-Borne Substances into the Brain
Current Neuropharmacology Antisense Technologies Targeting Fatty Acid Synthetic Enzymes
Recent Patents on Anti-Cancer Drug Discovery Retraction Notice: Protein Identification in Sub Proteome Fractions of Breast Cancer Cells by OFFGEL-IEF and iTRAQ Labeling
Current Proteomics Electrochemical DNA Detection Using Carbon Nanotubes
Current Physical Chemistry Genetic Enhancement in Sport: Just Another Form of Doping?
Recent Patents on DNA & Gene Sequences The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Nutrient-By-Genotype Interactions and Personalized Diet: What Can We Learn From Drosophila and Evolutionary Biology?
Current Pharmacogenomics and Personalized Medicine Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Network Pharmacology: Reigning in Drug Attrition?
Current Drug Discovery Technologies Current Strategies in the Modification of PLGA-based Gene Delivery System
Current Medicinal Chemistry Artificial Intelligence Techniques for Colorectal Cancer Drug Metabolism: Ontologies and Complex Networks
Current Drug Metabolism Trichinella spiralis and Tumors: Cause, Coincidence or Treatment?
Anti-Cancer Agents in Medicinal Chemistry Role of Cervical Cancer Radiotherapy in the Expression of EGFR and p53 Gene
Current Proteomics